About DEFLAZACORT API POWDER
Deflazacort API (Active Pharmaceutical Ingredient) powder is a synthetic glucocorticoid used primarily for its anti-inflammatory and immunosuppressive properties in treating conditions like Duchenne muscular dystrophy (DMD).
Advanced Pharmaceutical Ingredient for Targeted TherapiesDeflazacort API Powder is developed for use in the formulation of medicines targeting inflammatory and autoimmune conditions. Its high purity level and compliance with IP/BP/USP/EP standards make it a trusted choice for pharmaceutical manufacturers. The API exhibits reliable stability and efficacy, ensuring consistent results in drug development and production.
Secure and Flexible Packaging SolutionsOur product is meticulously packed in HDPE drums with double liner LDPE bags to maintain safety and stability throughout transit and storage. We offer customized packing sizes, ranging from 1 kg to 25 kg, catering to both bulk and small-scale requirements, with guaranteed protection from moisture and light.
FAQ's of DEFLAZACORT API POWDER:
Q: How is Deflazacort API Powder commonly used in pharmaceutical manufacturing?
A: Deflazacort API Powder is used primarily as the active ingredient in pharmaceutical formulations designed to treat inflammatory disorders, autoimmune diseases, Duchenne muscular dystrophy, and certain allergic conditions. Its anti-inflammatory and immunosuppressive properties make it vital in creating both adult and pediatric medication.
Q: What is the standard packaging process for Deflazacort API Powder?
A: The API is packed in HDPE drums, each lined with double LDPE bags to ensure product integrity and minimize exposure to environmental factors. Packaging sizes can be customized from 1 kg to 25 kg or as per client requirements, ensuring both safety and flexibility during transport and storage.
Q: When should Deflazacort API Powder be used during pharmaceutical production?
A: Deflazacort API Powder should be incorporated during the drug formulation stage, strictly following the prescriber's or pharmaceutical guidelines to ensure regulatory compliance and therapeutic effectiveness. Dosage should always be determined by a qualified healthcare professional.
Q: Where is Deflazacort API Powder manufactured and exported from?
A: This API is manufactured and exported from India, produced in GMP-compliant and ISO-certified facilities. It is supplied globally to pharmaceutical companies, with robust regulatory documentation available upon request.
Q: What are the storage instructions and shelf life of Deflazacort API Powder?
A: Deflazacort API should be stored in a cool, dry area, protected from moisture and direct light to maintain its stability and potency. The product has a shelf life of 36 months from the date of manufacture when stored under recommended conditions.
Q: What are the key benefits of using Deflazacort API Powder?
A: Benefits include high purity (99% HPLC), pharmaceutical-grade standards, stabilized packaging, DMF availability, and compliance with major pharmacopoeial standards (IP/BP/USP/EP). Its reliable anti-inflammatory and immunosuppressive action supports effective pharmaceutical formulations for various indications.